Muscle-invasive bladder cancer(MIBC)constitutes-25%of newly diagnosed bladder cancer cases.Patients with MIBC are optimally treated with platinum-based neoadjuvant chemotherapy(NAC)prior to radical cystectomy,which im...Muscle-invasive bladder cancer(MIBC)constitutes-25%of newly diagnosed bladder cancer cases.Patients with MIBC are optimally treated with platinum-based neoadjuvant chemotherapy(NAC)prior to radical cystectomy,which improves overall survival compared to surgery alone.While the goal of NAC is to downstage the primary tumor and afford early systemic treatment of micrometastasis,more than 60%of patients receiving NAC will not demonstrate significant local responses.Without accurate biomarkers predicting those that will benefit from NAC,a large cohort of patients will not only be exposed to the side effects of chemotherapy but also unnecessarily be subjected to delayed curative surgical intervention.This dilemma in the current management of patients with this aggressive disease highlights the importance of a recent discovery by Vollmer and colleagues,who reported that the intratumoral CXCR3alt-CXCL11 chemokine axis may be associated with the response to NAC in MIBC.展开更多
肺脏肿瘤是一种高发病率、高致死率疾病[1],在发展早期主要依赖NK细胞等淋巴细胞发挥抗肿瘤作用[2],其中CXCR3^(+)NK细胞可依赖CXCL9/10等趋化因子的招募作用[3]而快速迁移,并大量分泌IFN-γ和穿孔素等效应因子,发挥免疫监视等作用[4]...肺脏肿瘤是一种高发病率、高致死率疾病[1],在发展早期主要依赖NK细胞等淋巴细胞发挥抗肿瘤作用[2],其中CXCR3^(+)NK细胞可依赖CXCL9/10等趋化因子的招募作用[3]而快速迁移,并大量分泌IFN-γ和穿孔素等效应因子,发挥免疫监视等作用[4]。桔梗-姜半夏配伍(the combination of Platycodon Grandiflorum and Pinella Ternata,PG+PT)常用于肿瘤的临床治疗中[5]。本研究旨在探讨PG+PT对肺脏肿瘤微环境中NK细胞、特别是CXCR3+NK的免疫药理作用,以明确该配伍发挥抗肿瘤作用的部分药理机制。展开更多
目的:克隆人CXCR3B基因,并构建含有该目的基因的真核表达载体,获得稳定表达人CXCR3B分子的基因转染细胞株L929-huCXCR3B。方法:采用PCR方法从pMD19-T/huCXCR3A质粒中扩增人CXCR3B基因,通过双酶切装入真核表达载体pIRES2-EGFP中;脂质体...目的:克隆人CXCR3B基因,并构建含有该目的基因的真核表达载体,获得稳定表达人CXCR3B分子的基因转染细胞株L929-huCXCR3B。方法:采用PCR方法从pMD19-T/huCXCR3A质粒中扩增人CXCR3B基因,通过双酶切装入真核表达载体pIRES2-EGFP中;脂质体法转染L929细胞,G418加压筛选阳性克隆;分别用RT-PCR方法与免疫荧光技术分析阳性克隆中人CXCR3B在mRNA和蛋白水平的表达。MTT分析基因转染细胞株L929-huCXCR3B在Mig(monokineinduced by IFN-γ,IFN-γ诱导的单核因子)作用下的增殖能力。结果:成功克隆了人CXCR3B基因并构建了真核表达载体pIRES2-EGFP/huCXCR3B,转染该载体后获得了稳定表达人CXCR3B的基因转染细胞株L929-huCXCR3B,膜表面CX-CR3B分子的阳性表达率为93%。该基因转染细胞与其配体Mig共培养24、48及72 h,抑制率分别为41.44%、44.01%和24.80%。结论:L929-huCXCR3B细胞株的建立为研究CXCR3B信号转导及制备相应的单克隆抗体(mAb)奠定了基础。展开更多
文摘Muscle-invasive bladder cancer(MIBC)constitutes-25%of newly diagnosed bladder cancer cases.Patients with MIBC are optimally treated with platinum-based neoadjuvant chemotherapy(NAC)prior to radical cystectomy,which improves overall survival compared to surgery alone.While the goal of NAC is to downstage the primary tumor and afford early systemic treatment of micrometastasis,more than 60%of patients receiving NAC will not demonstrate significant local responses.Without accurate biomarkers predicting those that will benefit from NAC,a large cohort of patients will not only be exposed to the side effects of chemotherapy but also unnecessarily be subjected to delayed curative surgical intervention.This dilemma in the current management of patients with this aggressive disease highlights the importance of a recent discovery by Vollmer and colleagues,who reported that the intratumoral CXCR3alt-CXCL11 chemokine axis may be associated with the response to NAC in MIBC.
文摘肺脏肿瘤是一种高发病率、高致死率疾病[1],在发展早期主要依赖NK细胞等淋巴细胞发挥抗肿瘤作用[2],其中CXCR3^(+)NK细胞可依赖CXCL9/10等趋化因子的招募作用[3]而快速迁移,并大量分泌IFN-γ和穿孔素等效应因子,发挥免疫监视等作用[4]。桔梗-姜半夏配伍(the combination of Platycodon Grandiflorum and Pinella Ternata,PG+PT)常用于肿瘤的临床治疗中[5]。本研究旨在探讨PG+PT对肺脏肿瘤微环境中NK细胞、特别是CXCR3+NK的免疫药理作用,以明确该配伍发挥抗肿瘤作用的部分药理机制。
文摘目的:克隆人CXCR3B基因,并构建含有该目的基因的真核表达载体,获得稳定表达人CXCR3B分子的基因转染细胞株L929-huCXCR3B。方法:采用PCR方法从pMD19-T/huCXCR3A质粒中扩增人CXCR3B基因,通过双酶切装入真核表达载体pIRES2-EGFP中;脂质体法转染L929细胞,G418加压筛选阳性克隆;分别用RT-PCR方法与免疫荧光技术分析阳性克隆中人CXCR3B在mRNA和蛋白水平的表达。MTT分析基因转染细胞株L929-huCXCR3B在Mig(monokineinduced by IFN-γ,IFN-γ诱导的单核因子)作用下的增殖能力。结果:成功克隆了人CXCR3B基因并构建了真核表达载体pIRES2-EGFP/huCXCR3B,转染该载体后获得了稳定表达人CXCR3B的基因转染细胞株L929-huCXCR3B,膜表面CX-CR3B分子的阳性表达率为93%。该基因转染细胞与其配体Mig共培养24、48及72 h,抑制率分别为41.44%、44.01%和24.80%。结论:L929-huCXCR3B细胞株的建立为研究CXCR3B信号转导及制备相应的单克隆抗体(mAb)奠定了基础。
